Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
To be clear, this is a made-up scenario that would be illegal under current US law.
The law here is inconsequential. The only protection that is certain is for the data not to exist.
It’s very much not.